Compared with CD34+/CD38+ and CD34− cells, CD34+/CD38− cells can initiate AML in nonobese diabetic mice with severe combined immunodeficient disease (NOD/SCID mice) [27]. Here, CD38 is linked to acute myeloid leukemia.